Matthew A. Kutny, MD¹, Todd A. Alonzo, PhD², Yi-Cheng Wang, MS^3*, Rhonda Ries, MA^4*, Jason E. Farrar, M.D.⁵, Jaime M. Guidry Auvil, PhD^6*, Malcolm A. Smith, MD, PhD⁷, Daniela S. Gerhard, PhD^6*, Tanja M. Davidsen, PhD^6*, Patee Gesuwan^6*, Leandro C. Hermida^6*, Marco A Marra, PhD⁸, Andrew J. Mungall, PhD⁹, Richard Moore, PhD^8*, William Long, PhD^9*, Yussanne Ma, PhD^9*, Stuart Zong^9*, E. Anders Kolb, MD¹⁰, Alan S. Gamis, MD, MPH¹¹ and Soheil Meshinchi, MD, PhD⁴

¹Department of Pediatrics, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
²Keck School of Medicine, University of Southern California, Los Angeles, CA
³Children's Oncology Group, Monrovia, CA
⁴Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
⁶Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
⁷Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
⁸Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁹Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁰Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
¹¹Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO

Jad Chahoud, MD¹, Hagop M. Kantarjian, MD², Farhad Ravandi, MD², Koji Sasaki, MD², Guillermo Garcia-Manero, MD², Jorge E. Cortes, MD², Tapan Kadia, MD², Mark Brandt, BS^3* and Elias Jabbour²

¹University of Texas Hosuton Health Science Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Khaja Syed, M.S.^1*, Christine Pietsch, Ph.D.^1*, Amy Axel^2*, Ann Forslund, Ph.D.^1*, Kate Sasser, PhD^3* and Mark Salvati, Ph.D.^1*

¹Janssen Research and Development, Spring House, PA
²Janssen Research & Development, LLC, Spring House, PA
³Heme Disease Area Stronghold, Janssen Pharmaceutical R&D, Spring House, PA

Claudia Haferlach, MD¹, Kathleen Zieschang^1*, Susanne Schnittger, PhD¹, Tamara Alpermann^1*, Melanie Zenger^1*, Karolína Perglerová^2*, Wolfgang Kern, MD¹ and Torsten Haferlach¹

¹MLL Munich Leukemia Laboratory, Munich, Germany
²MLL2 s.r.o., Praha, Czech Republic

Tamara Alpermann^*, Claudia Haferlach, MD, Annette Fasan, PhD^*, Sonja Schindela^*, Wolfgang Kern, MD and Torsten Haferlach

MLL Munich Leukemia Laboratory, Munich, Germany

Simone Weber^1*, Tamara Alpermann^1*, Karolína Perglerová^2*, Susanne Schnittger, PhD¹, Torsten Haferlach¹, Claudia Haferlach, MD¹ and Wolfgang Kern, MD¹

¹MLL Munich Leukemia Laboratory, Munich, Germany
²MLL2 s.r.o., Praha, Czech Republic

Adam Lamble, MD¹, Yoko Kosaka, PhD^2*, Pierrette Lo, MS^3*, Fei Huang, PhD^4*, Kate Sasser, PhD^4*, Cristina E. Tognon, PhD^5,6*, Marc Loriaux, MD, PhD^7*, Jeffrey W. Tyner, PhD³, Brian J. Druker, MD^3,6 and Evan F. Lind, PhD^2,3*

¹Pediatric Hematology/Oncology, Oregon Health & Science University, Portland, OR
²Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR
³Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁴Heme Disease Area Stronghold, Janssen Pharmaceutical R&D, Spring House, PA
⁵Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁶Howard Hughes Medical Institute, Portland, OR
⁷Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR

Michele Cea, MD^1*, Antonia Cagnetta, MD^1*, Davide Lovera, MD^1*, Raffaella Grasso, PhD^2*, Nicoletta Colombo, PhD^2*, Micaela Bergamaschi, MD^1*, Sara Aquino, MD^3*, Fabio Guolo, MD^2*, Paola Minetto, MD^2*, Filippo Ballerini, MD^2*, Letizia Canepa, MD^1*, Sophia Adamia, PhD⁴, Alessio Nencioni^1*, Ivana Pierri, MD^5*, Marino Clavio^6*, Maurizio Miglino, PhD^2*, Marco Gobbi, MD^2* and Roberto Massimo Lemoli, MD²

¹University of Genoa, Genoa, Italy
²Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
³University of Genoa, genoa, Italy
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Hematology Clinic, IRCSS AOU S.Martino-IST, University of Genova, Genova, Italy
⁶Hematology, S. Martino University Hospital, Genova, Italy

Esther Onecha^1*, Joan Ballesteros², Jose L Rojas^2*, Jose M Sanchez^1*, Eva Barragan, PhD^3*, Inmaculada Rapado, PhD^1*, Santiago Barrio^4*, David Martinez, MD, PhD^5*, Pau Montesinos, MD^6*, Pilar Herrera, MD, PhD^7*, Carmen Burgaleta, MD^8*, Joaquin Martinez-López, MD.PhD^9* and Rosa M. Ayala, MD, PhD¹

¹Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
²Vivia Biotech, Madrid, Spain
³Clinical Pathology Service; Hospital Universitari y Politecnic La Fe, Valencia, Spain
⁴Mayo Clinic, Scottsdale, AZ
⁵Hematology, Hospital Universitario de la Fe, Valencia, Spain
⁶Hematology, Hospital Universitari i Politčcnic La Fe de Valencia, Valencia, Spain
⁷Hospital Universitario Ramón y Cajal, Madrid, Spain
⁸Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
⁹Hematology, Hospital 12 de Octubre, Madrid, Spain

Andrew P. Voigt^1*, Lisa Eidenschink Brodersen, PhD^1*, Robert B. Gerbing, MA^2*, Andrew J. Menssen^1*, Betsy A. Hirsch, PhD^2,3*, Susana C. Raimondi, PhD^2,4, Alan S. Gamis, MD, MPH^2,5, Todd A. Alonzo, PhD^2,6, Soheil Meshinchi, MD, PhD^2,7 and Michael R. Loken, PhD^1*

¹Hematologics Inc., Seattle, WA
²Children's Oncology Group, Monrovia, CA
³University of Minnesota Medical Center, Minneapolis, MN
⁴Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
⁵Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
⁶Keck School of Medicine, University of Southern California, Los Angeles, CA
⁷Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Jingjing Xie, PhD^1*, Zhigang Lu^1* and Chengcheng Zhang, PhD²

¹UT Southwestern, Dallas
²Deparment of Physiology, University of Texas Southwestern Medical Center, Dallas, TX

Lucy Chilton, PhD^1*, Christine Harrison, PhD FRCPath FMedSci¹, Anthony V. Moorman, PhD¹, Iona Ashworth^2*, Alan K. Burnett, MD, FRCP³, David Grimwade, PhD, FRCPath⁴ and Robert K Hills, MA MSc DPhil⁵

¹Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
²Cardiff University School of Medicine, Cardiff, United Kingdom
³Haematology, Haematology, NCRI Working Group, United Kingdom, Cardiff, United Kingdom
⁴Dept of Medical & Molecular Genetics, King's College London School of Medicine, London, United Kingdom
⁵Haematology, Cardiff University School of Medicine on behalf of the NCRI AML Working Group, Cardiff, United Kingdom

Genki Yamato, MD^1,2*, Norio Shiba, MD, PhD^1,2*, Yusuke Hara, MD^1,2*, Myoung-Ja Park, MD, PhD^1*, Manabu Sotomatsu^3*, Kentaro Ohki, MD, PhD^4*, Hitoshi Ichikawa, PhD^5*, Daisuke Tomizawa, MD, PhD⁶, Takashi Taga, MD, PhD^7*, Keizo Horibe, MD, PhD⁸, Akio Tawa, MD, PhD^9*, Hirokazu Arakawa, MD, PhD^2*, Souichi Adachi, MD, PhD¹⁰ and Yasuhide Hayashi, MD, PhD^1,11

¹Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
²Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
³Hematology/Oncology, Gunma Children's Medical Center, shibukawa, Japan
⁴Departmentof Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan
⁵Cancer Transcriptome Project, National Cancer Center, Tokyo, Japan
⁶Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
⁷Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
⁸Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
⁹Department of Pediatrics, National Hospital Organization, Osaka National Hospital, Osaka, Japan
¹⁰Department of Human Health Sciences, Kyoto University, Kyoto, Japan
¹¹Japanese Red Cross Gunma Blood Center, Maebashi, Japan

Silke Kapp-Schwoerer, MD^1*, Sibylle Cocciardi^1*, Jan Kroenke, MD^1*, Anna Dolnik, PhD^1*, Tamara J. Blätte^1*, Andrea Corbacioglu, PhD^1*, Verena I. Gaidzik, MD^1*, Peter Paschka, MD¹, Maria-Veronica Teleanu, MD^1*, Karlheinz Holzmann, PhD^2*, Gudrun Göhring, MD^3*, Felicitas Thol, MD⁴, Michael Heuser, MD⁴, Arnold Ganser, MD, PhD⁴, Richard F. Schlenk, MD¹, Hartmut Döhner, Prof. Dr.¹, Lars Bullinger, MD¹ and Konstanze Döhner, MD¹

¹Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
²University of Ulm, Genomics Core Facility, Ulm, Germany
³Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
⁴Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Anna Hecht^1*, Daniel Nowak, MD^2*, Florian Nolte^2*, Verena Nowak^2*, Julia Oblaender^2*, Thomas Buechner^3*, Karsten Spiekermann⁴, Wolf-Karsten Hofmann, MD¹ and Eva Lengfelder, MD^1*

¹Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
²Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
³Department of Hematology/Oncology, University of Muenster, Muenster, Germany
⁴Department of Internal Medicine III, Ludwig- Maximilians- Universität München, Munich, Germany

Kezhi Huang^1,2*, Min Yang^1,2*, Zengkai Pan^1*, Florian H. Heidel, MD³, Michaela Scherr, PhD^1*, Matthias Eder, M.D.^1*, Thomas Fischer, MD³, Guntram Buesche, MD⁴, Nils von Neuhoff, PhD^5*, Arnold Ganser, M.D.¹ and Zhixiong Li, MD^1,2

¹Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
³Department of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
⁴Department of Pathology, Hannover Medical School, Hannover, Germany
⁵Institute of Human Genetics, Hannover Medical School, Hannover, Germany

Hasan Mahmud, PhD^*, Frank JG Scherpen^*, Tiny Meeuwsen-de Boer^*, Harm Jan Lourens^* and Eveline S. de Bont

Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Wade L Schulz, MD, PhD¹, Thomas JS Durant, MD^1*, Henry Rinder, MD¹, Christopher A Tormey, MD^1,2*, Richard Torres, MD^1*, Brian R Smith, MD¹, Karl M Hager, PhD^1*, John G Howe, PhD¹ and Alexa J Siddon, MD¹

¹Department of Laboratory Medicine, Yale University, New Haven, CT
²Pathology and Laboratory Medicine Service, VA Connecticut Healthcare System, West Haven, CT

Amber Johnson^1*, Ann Marie Bailey^2*, Kenna Shaw^1*, Jorge E. Cortes, MD³, Tapan Kadia, MD⁴, Elias J Jabbour, MD⁴, Farhad Ravandi, MD⁴, Funda Meric-Bernstam^5*, Hagop M. Kantarjian, MD⁴, Gordon Mills^6* and Gautam Borthakur, MD⁴

¹Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, UT MD Anderson Cancer Center, Houston, TX
²Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, UT MD Anderson Cancer Center, Houston, TN
³Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, TX
⁶Systems Biology, UT MD Anderson Cancer Center, Houston, TX

Philipp J Rauch, MD^1,2*, Corinne Widmer, MD^1*, Kristin Fritsch, MS^1*, Jana M Ellegast, MD^1*, Jeroen S Goede, MD^1*, Peter J M Valk, PhD³, Hitoshi Takizawa, PhD^1* and Markus G Manz, MD¹

¹Division of Hematology, University Hospital Zurich, Zurich, Switzerland
²Department of Medicine, Boston University School of Medicine, Boston, MA
³Department of Hematology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Zeqiang Ma, PhD^1*, Jason Gottwals^2*, Hao Ho, MD/PhD^1*, Kristina J. Fasig, MD^3*, Heather Rietz, MD^1*, Taylor Hartley, MD^1*, Vladimir Kravstov, MD^1*, David C. Spence, MD⁴, Dan Connor, MD^1*, Ron Turnicky, DO^1*, James Prescott, PhD^1*, Patrick Lennon, PhD^1*, Malini Sathanoori, PhD^1*, Ian W. Flinn, MD, PhD^5,6, Jesus G. Berdeja, MD^5,6, William B. Donnellan, MD^5,6, Scott Wheeler, PhD^1*, Christopher Coldren, PhD^1*, Pranil Chandra, DO^1*, Sandeep Mukherjee, PhD^1* and Terence Casey, MD^1*

¹PathGroup, Nashville, TN
²PathGroup, Brentwood, TN
³Pathgroup, Brentwood, TN
⁴Pathgroup Inc, Chattanooga, TN
⁵Sarah Cannon Research Institute, Nashville, TN
⁶Tennessee Oncology, PLLC, Nashville, TN

Joshua M. Jackson, MS^1*, James Taylor, BS^1*, Malgorzata Witek, PhD^2*, Sally A. Hunsucker, PhD^3*, Jennifer Paulsen Waugh, MD^4*, Yuri D. Fedoriw, MD³, Thomas C. Shea, MD⁴, Steven A. Soper, PhD^2* and Paul M. Armistead, MD, PhD³

¹Department of Chemistry, University of North Carolina, Chapel Hill, NC
²Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC
³Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁴Department of Medicine, University of North Carolina, Chapel Hill, NC

Ritika Dutta, BS^*, Bruce Tiu^*, Arya Kaul^*, Bryan Mitton, MD, PhD and Kathleen M. Sakamoto, MD, PhD

Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA

Costakis Frangou, PhD^1,2*, Jason Den Haese, PhD^3,4*, Jordan Warunek^3*, Scott Portwood, MS, MBA^3*, Norma J Nowak, PhD^5*, Andrei V Gudkov, PhD^2*, Katerina Gurova, PhD^2*, Meir Wetzler, MD³ and Eunice S. Wang, MD³

¹Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY
²Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY
³Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
⁴Math and Natural Sciences, D'Youville College, Buffalo, NY
⁵Department of Biochemistry, University of Buffalo, Buffalo, NY

Parsa Hodjat, MD^1*, Kankana Ghosh, B. Pharm^2*, Priyanka Priyanka, MPH^3*, Beenu Thakral, MBBS, MD^1*, Keyur P. Patel, MD, PhD^1*, Mark Routbort, MD, PhD^1*, Rashmi Kanagal-Shamana, MD^1*, C. Cameron Yin, MD, PhD¹, Zhuang Zuo, MD, PhD^1*, Raja Luthra, PhD^1* and Tariq Muzzafar, MD¹

¹Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
²The University of Texas, School of Public Health, Houston, TX
³Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX

Bo Lei^*, Ju Bai^*, Wanggang Zhang^*, Aili He^*, Yinxia Chen^*, Pengyu Zhang^*, Lu Qian^* and Fuling Zhou^*

Department of Hematology, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China

Suning Chen^1*, Nana Ping^1*, Jia Yin^1*, Wenxiu Cheng^1*, Qinrong Wang^1*, Qian Wang^1*, Liang Ma^1*, Hong Yao^1*, Lijun Wen^1*, Yang Xu^1*, Hong Liu^1*, Zhengming Jin^1*, Mingqing Zhu^1*, Jianying Liang^1*, Dandan Liu^1*, Huiying Qiu^1*, Aining Sun, PhD^1*, Changgeng Ruan, MD, PhD² and Wu Depei, MD¹

¹Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China
²Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China

Sara Grace Rota, MSc^1*, Paul A Spagnuolo, Ph.D.², Leonard Angka^1*, Andrew Doxey^3*, Praveen Nekkar^4* and Mark D. Minden, MD, PhD⁵

¹University of Waterloo, Kitchener, ON, Canada
²School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
³University of Waterloo, Waterloo, ON, Canada
⁴University of Waterloo, Kitchener, Canada
⁵Princess Margaret Cancer Centre, University Health Network, Leukemia Program, Division of Medical Oncology and Hematology, Toronto, ON, Canada

Robert K Hills, DPhil¹, Claire M Lucas^2*, Laura J Scott^2*, Natasha Carmell^2*, Alison K Holcroft^2* and Richard E. Clark, MD^3*

¹Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom
²Depts of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
³Royal Liverpool University Hospital, Liverpool, United Kingdom

Marina Diaz-Beya, MD, PhD^1*, Alfons Navarro^2*, Anna Cordeiro^3*, Marta Pratcorona^4*, Joan Castellano^2*, Miguel Angel Torrente^5*, Meritxell Nomdedeu^6*, Ruth Risueńo^7*, Maria Rozman^8*, Mariano Monzo^2* and Jordi Esteve, MD, PhD⁹

¹Hematology Department, Hospital Clinic, IDIBAPS Barcelona. Josep Carreras Leukemia Reseach Institute, Barcelona, Spain
²Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, Barcelona, Spain
³2Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, Barcelona, Spain
⁴Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
⁵Hematology Department,Hospital Clinic Barcelona, IDIBAPS., Barcelona, Spain
⁶Hospital Clinic, Spanish MDS Cooperative Group, Barcelona, Spain
⁷Josep Carreras Leukaemia Research Institute, Barcelona, Spain
⁸Hospital Clínic, Barcelona, Spain
⁹Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain

Zhihong Zeng, MD¹, Wenbin Liu, PhD^2*, Twee Tsao, MS^3*, Yihua Qiu, MD^4*, Ismael Samudio, PhD^5*, Keith Baggerly, PhD^6*, Steven M. Kornblau, MD⁴, Hagop M Kantarjian, MD⁷, Michael Andreeff, MD, PhD⁸ and Marina Konopleva, MD, PhD¹

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX
³Leukemia Department, MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵CDRD - The Centre for Drug Research and Development, Vancouver, Canada
⁶Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX

Tara L. Lin, MD^1,2, Amanda Wise, MS^2*, Abigale Berry^2*, Joseph Fontes, PhD^3*, Partha Kasturi, PhD^4*, Brea C. Lipe, MD^1,2 and Omar S. Aljitawi, MD^1,2

¹Division of Hematology/Oncology, University of Kansas Medical Center, Kansas City, KS
²Hematology and Transplantation Research Laboratory, University of Kansas Medical Center, Kansas City, KS
³Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS
⁴Department of Pharmacology, University of Kansas Medical Center, Kansas City, KS

Stephen Sze Yuen Lam^1*, Chae Yin Cher^2*, Nelson K. L. Ng^2*, Cheuk Him Man, PhD^1* and Anskar Y.H. Leung, MD²

¹Department of Medicine, The University of Hong Kong, Hong Kong, China
²Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong

Croix Fossum, BS¹, Rhett P. Ketterling, MD^2*, Lindsey E. Roeker^1*, Ajoy L. Dias, MD^3*, Michelle Elliott, MD^3*, William J. Hogan, MBChB³, Mark R. Litzow, MD³ and Aref Al-Kali, MD³

¹Mayo Medical School, Rochester, MN
²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN

Heba M. Jalal El-Din^1* and Jasmeen S. Merzaban, PhD²

¹King Abdullah university of science and technology (Kaust), Thuwal, Saudi Arabia
²Division of Biological and Environmental Sciences & Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia

Carmen M Alonso*, MD^1*, Marta Llop*, PhD^2,3*, Mariam Ibáńez, PhD^3,4*, Jose Cervera, MD^4*, Esperanza Such, PhD^4*, Eva Villamon^3,4*, Sarai Palanca^2*, Inmaculada de Juan^2*, Rosa Murria^2*, Blanca de Unamuno^2*, Laia Pedrola^3*, Ivan Martin^3*, Pau Montesinos, MD^4*, Pascual Bolufer^2*, Miguel A. Sanz, MD, PhD⁴ and Eva Barragan, PhD^2*

¹Hematology Department, Hospital Arnau de Vilanova, Valencia, Spain
²Clinical Pathology Service; Hospital Universitari y Politecnic La Fe, Valencia, Spain
³Instituto de Investigación Sanitaria La Fe, Valencia, Spain
⁴Hematology Department, Hospital Universitari i Politecnic La Fe, Valencia, Spain

Subarna Sinha, PhD^1*, Daniel Thomas, MD, PhD², Steven M. Chan, MD, PhD³, Yang Gao^4*, Rolf Jansen, PhD^5*, Ravi Majeti, MD, PhD⁶ and David L Dill, PhD^1*

¹Computer Science, Stanford University, Palo Alto, CA
²Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA
³Stanford Cancer Institute, Stanford University, Stanford, CA
⁴Electrical Engineering and Computer Sciences, University of California at Berkeley, Berkeley, CA
⁵Helmholtz Center for Infection Research, Braunschweig, Germany
⁶Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA

Remco Molenaar, M.Sc.^1,2*, Srinivasa Reddy Sanikommu, MD³, Bhumika J. Patel^4*, Bartlomiej Przychodzen, MSc^5*, Cornelis J van Noorden, PhD^6*, Tomas Radivoyevitch, PhD^7*, Hideki Makishima, MD, Ph.D.^5,8, Hetty E. Carraway, MD, MBA⁹ and Jaroslaw P. Maciejewski, MD, PhD¹⁰

¹Department of Cell Biology & Histology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
²Translational Hematology & Oncology Research, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
³Departemnt of Translational Hematology and Oncology, Cleveland Clinic Taussing Cancer Institute, Cleveland, OH
⁴Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
⁶Department of Cell Biology & Histology, Academic Medical Center, Amsterdam, Netherlands
⁷Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
⁸Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁹Leukemia Program, Cleveland Clinic, Cleveland, OH
¹⁰Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Mohammad Omar Hussaini, MD^1*, Haipeng Shao, M.D., Ph.D.^1*, Lynn C. Moscinski, M.D.¹ and Jinming Song, MD, PhD^2*

¹Dept. of Hematopathology, Moffitt Cancer Center, Tampa, FL
²Hematopathology, Moffitt Cancer Center, Tampa, FL

Chin-Hin Ng, MD, MRCP, FRCPATH^1*, Ma Thin Mar Win, MBBS, MPH, MHM^2*, Elaine Seah, BSc^1* and Wee-Joo J Chng, MD, MRCP, FRCPATH, PhD^1,3

¹Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore, Singapore
²Biostatistics Unit, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
³Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Sylvia Herold, PhD^1,2*, Michael Kramer, MSc.^1*, Christoph Röllig, MD^1*, Matthias Kuhn^3*, Thoralf Stange^3*, Uwe Platzbecker, MD¹, Johannes Schetelig, MD, M.Sc^4,5, Hubert Serve, MD⁶, Gerhard Ehninger, MD¹ and Christian Thiede, MD⁷

¹Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany
²German Cancer Research Consortium (DKTK), Heidelberg, Germany
³Institute for Medical Informatics and Biometry, Dresden, Germany
⁴Medical Deptartment 1, University Hospital TU Dresden, Dresden, Germany
⁵DKMS German Bone Marrow Donor Center, Dresden, Germany
⁶Department for Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt am Main, Germany
⁷Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany